MedPath

Urea

Generic Name
Urea
Brand Names
Cem-urea, Umecta, Utopic
Drug Type
Small Molecule
Chemical Formula
CH4N2O
CAS Number
57-13-6
Unique Ingredient Identifier
8W8T17847W
Background

A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.

Indication

Urea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.

Associated Conditions
Allergic Skin Reaction, Atopic Dermatitis, Contact Dermatitis, Dermatitis, Dry Eyes, Dry Skin, Dry Skin; Eczema, Eczema, Dyshidrotic, Eye pruritus, Helicobacter Pylori Infection, Insect Bites, Lichen Planus (LP), Neurodermatitis, Nummular Dermatitis, Psoriasis, Seborrheic Dermatitis, Sunburn, Anal eczema, Calluses
Associated Therapies
Moisturizing

Emcutix and Mantra Pharma Launch Advanced Urea-Based Moisturizer for Hyperkeratotic Skin Conditions

• Emcutix Biopharmaceuticals and Mantra Pharma have launched Ureaderm, a urea-based moisturizer in 10% and 20% formulations designed for extremely dry skin and hyperkeratotic conditions like psoriasis and ichthyosis. • The product utilizes proprietary Multilayer Fatty Acid Emulsion (MLFAE) technology that enables sustained release of urea, providing continuous moisturization for up to 72 hours. • Ureaderm's formulation includes eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and allantoin to strengthen the skin's lipid barrier and reduce water loss, making it particularly effective for therapeutic skin management.
© Copyright 2025. All Rights Reserved by MedPath